New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
18:44 EDTPBPB, ATVI, ZGNX, TWX, SCTY, FSLR, NYMT, DRYS, FOXA, Z, CHUY, JAZZ, ZAGG, CYTX, XXIAOn The Fly: After Hours Movers
UP AFTER EARNINGS: Zogenix (ZGNX), up 8.21%... Zagg (ZAGG), up 8.9%... DryShips (DRYS), up 7%... Activision Blizzard (ATVI), up 3.1%... Jazz Pharmaceuticals (JAZZ), up 3%... New York Mortgage Trust (NYMT), up 1.4%... Potbelly (PBPB), up 1% after reporting second quarter results and announcing a $35M share repurchase program. DOWN AFTER EARNINGS: Chuy's Holdings (CHUY), down 6% after reporting second quarter results below analyst estimates and lowering fiscal 2014 guidance... First Solar (FSLR), down 4.1%... Ixia (XXIA), down 1.4% after reporting preliminary first quarter EPS below analyst estimates... Zillow (Z), down marginally after reporting quarterly results. ALSO LOWER: SolarCity (SCTY), down 1.4% after First Solar reported second quarter results... Cytori Therapeutics (CYTX), down 28.6% after announcing that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. NOTABLE: Twenty-First Century Fox (FOXA), up 7.8% after announcing that it has withdrawn its proposal to acquire Time Warner (TWX) and announcing a $6B share repurchase program... Time Warner is trading down 9.8%.
News For ZGNX;ZAGG;DRYS;ATVI;JAZZ;NYMT;PBPB;CHUY;FSLR;XXIA;Z;SCTY;CYTX;FOXA;TWX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
February 17, 2015
18:17 EDTSCTYJANA Partners gives quarterly update on stakes
NEW STAKES: NCR (NCR), Liberty Ventures (LVNTA), Solarcity (SCTY), Computer Sciences Corp (CSC), Salix (SLXP), and Applied Materials (AMAT). INCREASED STAKES: Hertz (HTZ), Valeant (VRX), Walgreens Boots Alliance (WBA), Rackspace (RAX), and HD Supply (HDS). DECREASED STAKES: AIG (AIG), Actavis (ACT), Charter (CHTR), AerCap (AER), and Energy Transfer Equity (ETE). LIQUIDATED STAKES: Equinix (EQIX), Cameron International (CAM), Dollar General (DG), QEP Resources (QEP), and Amgen (AMGN).
17:29 EDTFOXABerkshire Hathaway gives quarterly update on stakes, exits Exxon Mobil
Subscribe for More Information
16:45 EDTZZillow names former Trulia COO Paul Levine President
Subscribe for More Information
16:44 EDTZZillow completes Trulia acquisition, to eliminate 350 jobs
Subscribe for More Information
16:15 EDTPBPBPotbelly expects at least 20% annual adjusted net income growth in FY15
Subscribe for More Information
16:14 EDTPBPBPotbelly reports Q4 adj. EPS 6c, consensus 3c
Subscribe for More Information
14:08 EDTSCTYSolarCity volatility elevated into Q4 and outlook
Subscribe for More Information
13:18 EDTTWXOmega Advisors gives quarterly update on stakes
Subscribe for More Information
12:56 EDTFOXADecline of TV viewing accelerated, NY Post reports
Subscribe for More Information
11:06 EDTZZillow volatility elevated on wide price movement
Subscribe for More Information
10:30 EDTSCTYSolarCity spikes higher, levels to watch
The stock spiked to session highs after being in decline from the open. At last price of $58.68, resistance is at the session spike high of $59.10 and then at $59.69. Support is at $58.38, the opening price of the day.
10:28 EDTSCTYJANA Partners reports 5.4% passive stake in SolarCity
Subscribe for More Information
10:18 EDTSCTYSolarCity management to meet with Roth Capital
Subscribe for More Information
09:40 EDTZActive equity options trading on open
Subscribe for More Information
08:25 EDTZZillow Q4 preannouncement shows revenue momentum, says Canaccord
Canaccord said Zillow's (Z) Q4 earnings preannouncement shows that it is gaining revenue momentum. The firm believes the future is bright for the company, which is set to close its purchase of Trulia (TRLA) as soon as today. Canaccord maintained its Buy rating and $125 price target on Zillow shares.
08:10 EDTSCTYTop U.S. solar ideas into Q4 at Goldman
Subscribe for More Information
08:03 EDTCYTXCytori Therapeutics begins enrollment in Phase II ACT-OA trial
Cytori Therapeutics announced that the first patient has been treated in its FDA approved trial assessing the effect of Cytori Cell Therapy for osteoarthritis of the knee. The patient was treated by Dr. Peter Hanson, Medical Director of Orthopedic Surgery at Sharp Grossmont Hospital. ACT-OA is a Phase II FDA approved randomized, double-blind, placebo controlled trial in 90 patients evaluating the efficacy and safety of Cytori’s autologous adipose derived therapy ECCO-50 (Cytori’s therapeutic under study). The trial tests both a low dose and a high dose vs. placebo and will be conducted over 48 weeks. The randomization will be 1:1:1 between the control, low dose and high dose groups. The primary end point will be pain on walking as measured by the Knee Injury and Osteoarthritis Outcome Score at 12 weeks. Secondary endpoints assessed will include pain, joint function, magnetic resonance imaging and adverse events.
07:15 EDTFOXA'Fifty Shades' opens to $94.4M, WSJ says
Comcast (CMCSA, CMCSK) subsidiary Universal's "Fifty Shades of Grey" earned roughly $94.4M in its opening weekend, reports the Wall Street Journal. The film earned an additional $172M overseas. Fox' (FOX, FOX.A) "Kingsman: The Secret Service" debuted in second place with $42M, and Viacom (VIA, VIA.B) subsidiary Paramount's "SpongeBob SquarePants: Sponge Out of Water" took $40M in its second week. Reference Link
05:50 EDTZZillow to host conference call
Subscribe for More Information
05:16 EDTPBPBPotbelly volatility elevated into Q4 and outlook
Potbelly February call option implied volatility is at 146, March is at 61, July is at 51; compared to its 19-week average of 48 according to Track Data, suggesting larger near term price movement into the expected release of Q4 results today.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use